Chicago Biotech Company BIOLIFE4D, just announced it had successfully 3D-
The mini heart was printed with cardiac muscle cells that was derived from a patient including cardiomyocytes, and bioink made from extracellular matrix compounds which allow them to replicate the properties of the mammalian heart. The scientific milestone was accomplished at the Company’s research facility at JLABS in Houston, and led by Dr. Ravi Birla, the Company’s Chief Science Officer.
We are extremely proud of what we have accomplished, from the ability to 3DDr. Ravi Birla, Chief Science Officer, BIOLIFE4D
bioprinthuman cardiac tissue last summer to a mini heart with t he full structure now. These milestones are a testament to the hard work of our team and the proprietary process we have developed that enables this type of scientific achievement, We believe we are at the forefront of whole heart bioengineering, a field that has matured quickly over the last year, and well-positioned to continue our rapid scientific advancement. Today is an exciting day, but we continue forward earnestly toward the end goal of 3D bioprinting whole human hearts.
BIOLIFE4D is a pioneering biotech company laser-focused on leveraging advances in life sciences and tissue engineering to 3D